Adenocarcinoma, Clear Cell
Showing 9976 - 10000 of >10,000
Leukemia, Myeloid, Acute Trial in Worldwide (Cytarabine, Idasanutlin, Placebo)
Non Small Cell Lung Cancer Trial in Philadelphia (Endobronchial ultrasound (EBUS) transbronchial needle aspirate (TBNA))
Completed
- Non Small Cell Lung Cancer
- Endobronchial ultrasound (EBUS) transbronchial needle aspirate (TBNA)
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Oct 7, 2020
Relapsed Neuroblastoma, Metastatic Pheochromocytoma Trial in Minneapolis (131 I-Metaiodobenzylguanidine (131I-MIBG), Potassium
Recruiting
- Relapsed Neuroblastoma
- Metastatic Pheochromocytoma
- 131 I-Metaiodobenzylguanidine (131I-MIBG)
- +3 more
-
Minneapolis, MinnesotaUniversity of Minnesota Masonic Cancer Center
Jan 20, 2022
Relapsed/Refractory Multiple Myeloma Trial in United States (Ipilimumab)
Recruiting
- Relapsed/Refractory Multiple Myeloma
-
Basking Ridge, New Jersey
- +6 more
Jan 21, 2022
A Retrospective Pharmacogenomics Research of EGFR-TKIs,Gefitinib
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- +4 more
-
Guangzhou, Guangdong, ChinaCancer Center, Sun Yat-sen University
Oct 25, 2022
Hashimoto Thyroiditis, Hashimoto Disease Trial in Istanbul (mediterranean, gluten-free and mediterranean gluten-free diet
Completed
- Hashimoto Thyroiditis
- Hashimoto Disease
- mediterranean, gluten-free and mediterranean gluten-free diet intervention
-
Istanbul, TurkeyIstınye University
Jul 10, 2023
Hair Disease Trial in Irvine (Intradermal Injection in hair loss, Platelet Rich Plasma, Adipose Derived Stem/Stromal Cells)
Enrolling by invitation
- Hair Disease
- Intradermal Injection in hair loss
- +7 more
-
Irvine, CaliforniaKenneth Williams, DO
Aug 1, 2022
NSCLC Trial in China (DZD9008, Pemetrexed+carboplatin)
Not yet recruiting
- Non-small Cell Lung Cancer
-
Beijing, China
- +40 more
Dec 20, 2022
Contribution ofHigh-resolution Diffusion Sequence at 3T for
Not yet recruiting
- Stroke
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Dec 8, 2022
Peripheral Nerve Injury Trial in Miami (Autologous Human Schwann Cell)
Not yet recruiting
- Peripheral Nerve Injury
- Autologous Human Schwann Cell
-
Miami, FloridaUniversity of Miami
Sep 13, 2022
Chronic Low Back Pain, Degenerative Disc Disease Trial in Baltimore (Autologous stem cells, Corticosteroid, Local anesthetic)
Suspended
- Chronic Low Back Pain
- Degenerative Disc Disease
- Autologous stem cells
- +2 more
-
Baltimore, MarylandJohns Hopkins Hospital
Nov 29, 2022
Eliminating Need for Pancreas Biopsy Using Peripheral Blood
Recruiting
- Transplant;Failure,Kidney
- +3 more
- dd-cfDNA Blood Test
-
Washington, District of Columbia
- +2 more
Feb 23, 2022
BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,
Recruiting
- BRAF NP_004324.2:p.V600M
- +6 more
- Binimetinib
- +2 more
-
Portland, OregonProvidence Portland Medical Center
Aug 17, 2022
NSCLC Trial in Shanghai (Pembrolizumab, Paclitaxel, Nab-paclitaxel)
Active, not recruiting
- Non-small Cell Lung Cancer
- Pembrolizumab
- +4 more
-
Shanghai, ChinaZhongshan Hospital Fudan University
Aug 18, 2022
Cardiac Surgical Procedures, Extracorporeal Circulation; Complications, Acute Kidney Injury Trial in Gothenburg (Colloid priming
Recruiting
- Cardiac Surgical Procedures
- +2 more
- Colloid priming solution for ECC circuit
- Standard priming solution for ECC circuit
-
Gothenburg, Västra Götalands Län, SwedenSahlgrenska University Hospital
Apr 21, 2022
Multiple Myeloma Trial in Iowa City (Ascorbate, Melphalan)
Recruiting
- Multiple Myeloma
- Ascorbate
- Melphalan
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Dec 31, 2021
Bronchiolitis Obliterans Trial in Bordeaux (lung MRI)
Recruiting
- Bronchiolitis Obliterans
- lung MRI
-
Bordeaux, FranceCHU Bordeaux
Apr 11, 2022
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL, Recurrent Hodgkin Lymphoma Trial in New York (Decitabine and
Recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +5 more
- Decitabine and Cedazuridine
- Nivolumab
-
New York, New YorkNY011 Laura and Isaac Perlmutter Cancer Center at NYU Langone
Jul 8, 2022
Leukemia, Acute Lymphocytic (ALL), Leukemia, Acute Myelogenous (AML), MDS Trial in Guangzhou (Chimeric antigen receptor T cells,
Recruiting
- Leukemia, Acute Lymphocytic (ALL)
- +2 more
- Chimeric antigen receptor T cells
- peptide specific dendritic cell
-
Guangzhou, Guangdong, ChinaZhujiang Hospital, Southern Medical University
Aug 1, 2021
Vitamin A and E Deficiency With Severity of SARS-COV-2 Disease:
Completed
- COVID-19
-
Cairo, None Selected, Egyptbalsam Sherif Fahmy
Jul 12, 2023
COVID-19 Pandemic on Management of Type 2 DiabeticSample in
Recruiting
- COVID-19
- Diabetes Mellitus, Type 2
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Jun 29, 2022
SARS-CoV-2 Infection Trial in United States (Evusheld (tixagevimab+cilgavimab) IM or IV)
Recruiting
- SARS-CoV-2 Infection
- Evusheld (tixagevimab+cilgavimab) IM or IV
-
Fountain Valley, California
- +33 more
Jun 24, 2022
Role of HIV-1 Tat Protein and Anti-Tat Immune Response In HIV
Recruiting
- HIV/AIDS
- No intervention
-
Rome, ItalyInfectious Dermatology STI Unit San Gallicano Dermatologic Insti
Mar 23, 2022